TCG Lifesciences plans IPO
TCG Lifesciences has filed papers with the Securities & Exchange Board of India for initial public offering.
By INDIATIMES NEWS NETWORK |
MUMBAI: TCG Lifesciences has filed papers with the Securities & Exchange Board of India for initial public offering. The company proposes to issue 95 lakh equity shares of Rs 10 each at a price to be decided through 100 per cent book-building process. It is also considering a pre-IPO placement of up to 15 lakh shares with certain investors.
Net public issue of 9 lakh shares will constitute 13.65 per cent of the fully diluted post issue paid-up capital.
TCG Lifesciences plans to utilise the issue proceeds to finance capital expenditure, finance capital investments in subsidiaries, and repay debt.
The company offers solutions in discovery research, translational research, clinical development and enterprise informatics to the global life sciences industry.
Promoted by Dr Purnendu Chatterjee and TCG Lifesciences Mauritius with operations in India, the UK and US, its facilities are located at Kolkata, Mumbai, New Delhi, Pune, New Jersey and High Wycombe.
The equity shares are proposed to be listed on the National Stock Exchange and Bombay Stock Exchange.
Kotak Mahindra Capital and Enam Securities are book running lead managers to the issue.
Net public issue of 9 lakh shares will constitute 13.65 per cent of the fully diluted post issue paid-up capital.
TCG Lifesciences plans to utilise the issue proceeds to finance capital expenditure, finance capital investments in subsidiaries, and repay debt.
The company offers solutions in discovery research, translational research, clinical development and enterprise informatics to the global life sciences industry.
Promoted by Dr Purnendu Chatterjee and TCG Lifesciences Mauritius with operations in India, the UK and US, its facilities are located at Kolkata, Mumbai, New Delhi, Pune, New Jersey and High Wycombe.
The equity shares are proposed to be listed on the National Stock Exchange and Bombay Stock Exchange.
ADVERTISEMENT
Kotak Mahindra Capital and Enam Securities are book running lead managers to the issue.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
